4-[2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-a,a-dimethylbenzeneacetic acid

CAS : 202189-78-4

Ref. 3D-FE18595

Informations sur le produit

• Nom: 4-[2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-a,a-dimethylbenzeneacetic acid
• Synonymes: Bilastine, 2-[-4-(2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl)phenyl]-2-methylpropanoic acid, 2-[4-(2-{4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]piperidin-1-yl}ethyl)phenyl]-2-methylpropanoic acid, 4-[2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethylbenzeneacetic acid, Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-

Description

4-[2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-a,a-dimethylbenzeneacetic acid is a drug that belongs to the class of pharmacological agents. It is used to treat allergic symptoms and is intended for use in patients who are not responding to other therapies. This drug has been shown to be safe and effective in treating allergic rhinitis with or without conjunctivitis. The pharmacokinetics of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-a,a-dimethylbenzeneacetic acid are linear over the clinically relevant dose range and show no evidence of any significant interactions with other drugs. It has also been shown to have no effect on hepatic function or renal function in patients

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 463.61 g/mol
• Formule: C₂₈H₃₇N₃O₃
• Degré de pureté: Min. 95%